Merit Medical to acquire C2 CryoBalloon assets from Pentax of America
Merit Medical Systems has entered into a definitive agreement to acquire the C2 CryoBalloon device and its associated technology from…
Gastrointestinal
-
-
Exero Medical completes enrolment for US study of xBar system
Exero Medical has completed the enrolment phase for its US clinical trial designed to evaluate its xBar system in detecting…
-
Exact Sciences to acquire US rights for Freenome’s blood-based CRC test
Freenome has entered an exclusive licence agreement with Exact Sciences, granting the latter the rights to commercialise Freenome's blood-based colorectal…
-
Exact Sciences expands partnership with Humana to improve colorectal cancer screening
Exact Sciences has expanded its collaboration with private insurer Humana to make the Cologuard Plus test available to eligible Humana…
-
Viome and Scripps Research to develop precancerous colon polyps’ detection test
A collaboration between Viome Life Sciences and Scripps Research is set to develop and clinically validate the first ribonucleic acid (RNA)…
-
Mainz enrols first subject in study to evaluate colorectal cancer test
Mainz Biomed has enrolled the first subject in its eAArly DETECT 2 feasibility study, aimed at evaluating the company's colorectal…
-
Biomerica’s tests for IBD conditions gain CE-marking under EU’s IVDR
Biomerica has received CE-marking for its food intolerance tests tailored for ulcerative colitis (UC) and Crohn's disease, under the EU's…
-
ICR scientists develop algorithm that predicts bowel cancer risk in IBD patients
Scientists from the Institute of Cancer Research (ICR), London, UK, have developed an algorithm that can predict whether individuals with…
-
Natera reports new data from Phase III study of colorectal cancer detection test
Natera has reported the latest data from the Phase III CALGB (Alliance)/SWOG 80702 study, indicating that Signatera, a molecular residual…
-
Mainz Biomed partners with Quest for colorectal cancer screening test
Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal cancer screening test,…
